2m 2m 2m 2m 2m 2m 2m
FENNEC PHARMA (FENC)
NASDAQ
$10.22-$0.12 (-1.11%)
Price as of Oct 02, 2026 4:15 PM EDT- $362.2MMarket Cap
- 6.83%1-Year Change
- BiotechnologyIndustry
FENNEC PHARMA (FENC)
$10.22-$0.12 (-1.11%)
FENC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.33 | ||
Change | -$0.32 (-3.00%) | ||
Open | $10.58 | ||
High | $10.65 | ||
Low | $10.14 | ||
Previous Close | $10.65 | ||
Volume | 130,152 | ||
30-Day Average Volume | 191,919 | ||
1-Week Change | -2.73% | ||
1-Month Change | -14.13% | ||
1-Year Change | 6.83% | ||
3-Year Change | 37.55% | ||
5-Year Change | 10.84% | ||
Fundamentals | |||
Shares Outstanding | 35.1M | ||
Total Assets | $75.8M | ||
Market Cap | $362.2M | ||
Enterprise Value | $320.9M | ||
Period: QTR TTM FY | |||
Revenue | $17.2M | ||
Net Income | $2.0M | ||
Free Cash Flow | $50,000.00 | ||
EBIT | $2.0M | ||
EBITDA | $2.0M | ||
Net Working Capital | $60.1M | ||
EPS | $0.05 | ||
Enterprise Value/EBITDA | 157 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 9 | ||
P/E | 207 | ||
PEG | 1 | ||
Price/Free Cash Flow | 7,243 | ||
Price/Operating Cash Flow | 7,243 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue